BLNP-025

N/A

Report date: 2023/01/07 18:17:57
NME

Base Information

Drug NameBLNP-025
Drug Alias NameBLNP-025
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesBl&H Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBl&H Co Ltd
Inactive CompaniesN/A
Active IndicationsLeukemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A